Clinical Trials Browser

Unknown × Glioblastoma × Temozolomide × Clear all

NCT01107522 2025-09-09

Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas

Phase 1 Unknown

Glioblastoma, Glioma

NCT05638451 2024-06-05

Sintilimab in Combination With Bevacizumab and Temozolomide in Recurrent Glioblastoma (GBM) Patients

Phase 2 Unknown

Glioblastoma

NCT02137759 2023-05-06

MRSI to Predict Response to RT/TMZ ± Belinostat in GBM

Phase 2 Unknown

Glioblastoma

NCT02761070 2023-03-08

RE-GEND

Phase 3 Unknown

Glioblastoma, Recurrence, Disease Progression

NCT05700955 2023-01-26

Neoadjuvant Chemoimmunotherapy in Recurrent Glioblastoma

Phase 1 Unknown

Glioblastoma

NCT04077866 2022-12-28

B7-H3 CAR-T for Recurrent or Refractory Glioblastoma

Phase 1/2 Unknown

Glioblastoma

NCT04385173 2022-12-28

Pilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory Glioblastoma

Phase 1 Unknown

Glioblastoma

NCT05663125 2022-12-23

LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas

Phase 1/2 Unknown

Glioblastoma

NCT05600491 2022-10-31

A Phase III Study of Postoperative Early Temozolomide Treatment Plus STUPP Regimen for Newly Diagnosed GBM Multiforme

Phase 3 Unknown

Glioblastoma

NCT03243461 2022-06-06

HIT-HGG-2013

Phase 3 Unknown

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Neoplasms, Neuroepithelial

NCT03008148 2021-05-11

Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM

Phase 2/3 Unknown

Glioblastoma

NCT04829097 2021-04-02

Neoadjuvant Temozolomide Combined With Simultaneous IMRT for Treatment of Glioblastoma

Phase 3 Unknown

Glioblastoma

NCT04674527 2020-12-19

Pilot Study of Elemene in Treating Patients With Refractory Glioblastoma

Phase 2 Unknown

Glioblastoma

NCT04583020 2020-11-30

Neoadjuvant PD-1 in Newly Diagnosed Glioblastoma

Phase 2 Unknown

Glioblastoma

NCT03463733 2020-10-08

HUTMZ

Phase 1 Unknown

Glioblastoma, Glioma

NCT04552977 2020-09-17

A Trail of Fluzoparil in Combination With Temozolomide in Patients With Recurrent Glioblastoma

Phase 2 Unknown

Glioblastoma

NCT04388033 2020-06-09

Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients.

Phase 1/2 Unknown

Glioblastoma, Glioma, Neoplasms, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Neoplasms, Neuroepithelial

NCT03567135 2020-03-03

Temozolomide Plus Anti-angiogenesis Drugs and Radiotherapy as a Treatment for Glioblastoma

Glioblastoma

NCT00275067 2020-02-25

Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery

Phase 1/2 Unknown

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT04224441 2020-01-13

RACTAC

Phase 2 Unknown

Glioblastoma

NCT04157478 2019-11-12

Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed Glioblastoma

Phase 2 Unknown

Glioblastoma

NCT03687034 2019-02-26

A Study of the Safety and Pharmacokinetics of BRCX014 in Patients With Glioblastoma

Phase 1 Unknown

Glioblastoma

NCT03780569 2018-12-20

TTFields Together With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GBM

Phase NA Unknown

Glioblastoma

NCT03633552 2018-08-16

Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma

Phase 3 Unknown

Astrocytoma, Glioblastoma

NCT03607643 2018-07-31

A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies

Phase 1/2 Unknown

CNSGastrointestinalPlasma cell

Colonic Neoplasms, Gallbladder Neoplasms, Glioblastoma, Liver Neoplasms, Multiple Myeloma, Pancreatic Neoplasms, Rectal Neoplasms

NCT01765088 2018-02-23

A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas

Phase 3 Unknown

Astrocytoma, Glioblastoma, Glioma

NCT03225963 2017-07-24

Application of Proteome Profiler Antibody Arrays to Find Angiogenetic Predictors in Glioma Paitents.

Glioblastoma

NCT02928575 2016-10-10

Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma

Phase 2 Unknown

Glioblastoma

NCT02663440 2016-01-26

Trial of Hypofractionated Intensity Modulated Radiation Therapy With Temozolomide and Granulocyte-macrophage Colony-stimulating Factor for Patients With Newly Diagnosed Glioblastoma Multiforme

Phase 2 Unknown

Glioblastoma

NCT01939574 2016-01-21

A Explore Study of Bevacizumab Combined With Conventional Therapy in Glioblastoma

Phase NA Unknown

Glioblastoma

NCT00083096 2015-02-10

Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas

Phase 1 Unknown

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Glioma, Subependymal, Gliosarcoma

NCT00516607 2015-02-10

Enzastaurin and Temozolomide in Treating Patients With Primary Gliomas

Phase 1 Unknown

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT00492687 2014-01-10

Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas

Phase 2 Unknown

Astrocytoma, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00014105 2013-12-04

Combination Chemotherapy in Treating Patients With Recurrent Glioblastoma Multiforme

Phase 1/2 Unknown

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT01124240 2011-07-26

ExCentric

Phase 2 Unknown

Glioblastoma

NCT01181193 2011-03-29

Vitamin D for Treatment of Glioblastoma Multiforme

Phase 1/2 Unknown

Glioblastoma

NCT00768911 2010-10-27

CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma Multiforme

Phase 1 Unknown

Glioblastoma

NCT00643825 2010-07-23

PATSGO

Phase 2 Unknown

Glioblastoma

NCT00521482 2007-08-28

Temozolomide vs. Temozolomide and Thalidomide Treatment in Recurrent Glioblastoma

Phase 2 Unknown

Glioblastoma, Recurrence

NCT00311857 2006-09-08

Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT)

Phase 1/2 Unknown

Glioblastoma